Aptevo Therapeutics Inc. (APVO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -7.96M | -5.24M | -6.69M | -7.09M | -6.58M | -5.76M | -5.22M | -6.15M | -6.65M | -5.25M | -6.24M | -4.8M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -21.14% | 9.08% | -28.07% | -15.28% | 1.14% | -9.63% | 16.31% | -28.11% | -245.66% | 11.55% | 9.51% | -56.45% |
| Net Income | -6.79M | -5.81M | -7.55M | -6.2M | -6.41M | -6.31M | -5.1M | -5.88M | -6.83M | -6.2M | -6.33M | -7.95M |
| Depreciation & Amortization | 35K | 81K | 49K | 49K | 61K | 71K | 84K | 91K | 106K | 116K | 123K | 150K |
| Stock-Based Compensation | 0 | 2K | 77K | -163K | 180K | -72K | 149K | 273K | 719K | 0 | 455K | 465K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -778K | 349K |
| Other Non-Cash Items | 425K | 1.09M | 0 | 0 | -814K | 0 | -1.63M | 0 | 0 | 651K | 778K | -349K |
| Working Capital Changes | -1.63M | -602K | 735K | -775K | 406K | 554K | 1.28M | -634K | -642K | 176K | -485K | 2.53M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 13K | 434K | 724K | -501K | 0 | 324K | 1.8M | -879K | -926K | 389K | -76K | 1.11M |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 871K | 5.79M | 18.34M | 14.36M | 0 | 6.72M | 4.91M | 3.97M | -3K | 3.05M | 4.34M | 481K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 872K | 5.24M | 18.34M | 14.36M | 0 | 1.16M | 4.91M | 3.97M | 0 | 3.05M | 1.2M | 481K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -1K | 557K | 0 | 0 | 0 | 5.56M | 0 | -1K | -3K | -2K | 3.15M | 0 |
| Net Change in Cash | -7.09M | 558K | 11.65M | 7.27M | -6.58M | 961K | -313K | -2.18M | -6.65M | -2.21M | -1.9M | -4.32M |
| Free Cash Flow | -7.96M | -5.24M | -6.69M | -7.09M | -6.58M | -5.76M | -5.22M | -6.15M | -6.65M | -5.25M | -6.24M | -4.8M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -21.14% | 9.08% | -28.07% | -15.28% | 1.14% | -9.63% | 16.31% | -28.11% | -245.66% | 11.55% | 9.57% | -55.19% |
| FCF per Share | -7.51 | -1659.59 | -29.73 | -172.97 | -1623.06 | -1421.62 | -6594.04 | -23284.34 | -129003.65 | -158138.96 | -290733.43 | -434260.17 |
| FCF Conversion (FCF/Net Income) | 1.19x | 0.90x | 0.89x | 1.14x | 1.03x | 0.91x | 1.02x | 1.05x | 0.97x | 0.89x | 0.99x | 0.60x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |